Safety of rofecoxib in nonsteroidal anti-inflammatory drugs intolerance
Author:
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1398-9995.2003.00166.x/fullpdf
Reference22 articles.
1. Aspirin-induced asthma: Advances in pathogenesis and management☆☆☆
2. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
3. The Coxibs, Selective Inhibitors of Cyclooxygenase-2
4. Rofecoxib: clinical pharmacology and clinical experience
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity;The Journal of Allergy and Clinical Immunology: In Practice;2019-11
2. An alternative anti-inflammatory drug can be found to treat the majority of patients with asthma and aspirin hypersensitivity;Drugs & Therapy Perspectives;2007-10
3. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature;Archives of Dermatological Research;2007-05-11
4. Cutaneous Hypersensitivity Reactions to Inhibitors of Cyclooxygenase-2;Allergy & Clinical Immunology International - Journal of the World Allergy Organization;2007
5. Use of Nonsteroidal Anti-Inflammatory Drugs in Patients with Aspirin Hypersensitivity;Treatments in Respiratory Medicine;2006
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3